You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 9, September 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Nursing Care
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Alert me on articles by topic

The Impact of a Skilled Nursing Facility on the Cost of Surgical Treatment of Major Head and Neck Tumors

Hadi Seikaly, MD, FRCSC; Karen H. Calhoun, MD; Jana S. Stonestreet, RN, MSN; Christopher H. Rassekh, MD; Brian P. Driscoll, MD; Phylis Averyt, CPA

Arch Otolaryngol Head Neck Surg. 2001;127:1086-1088.

Background  The finite resources available for health care and the proliferation of managed care in the United States have forced the head and neck surgeon to critically evaluate the cost of tumor treatment.

Objective  To determine whether the cost of treating patients with head and neck tumors would be reduced if the patients were to spend a portion of what would otherwise be acute care hospital days in a hospital-based skilled nursing facility (HB/SNF).

Design  Retrospective cost-benefit analysis.

Setting  Tertiary referral center.

Patients  Twenty-four consecutive hospital admissions for definitive surgical treatment of head and neck tumors were retrospectively reviewed. The postoperative day on which the patient theoretically could have been transferred to the HB/SNF was determined. The charges and cost of each patient's actual hospital stay were compared with the theoretical counterparts had the patient been transferred to the HB/SNF on the determined day.

Main Outcome Measure  Cost savings.

Results  The total hospital stay for the 24 patients was 524 days. One hundred eighty-two of those days could have been spent in the HB/SNF. The total charge and cost savings with the use of an HB/SNF were $201 045 and $84 238, respectively (15% of the total charge and cost). This represents an average charge and cost savings of $8377 and $3510, respectively, per patient. The difference was statistically significant (P<.005).

Conclusion  An HB/SNF could reduce the cost of head and neck tumor treatment without compromising patient care.


From the Division of Otolaryngology–Head and Neck Surgery, University of Alberta, Edmonton (Dr Seikaly); the Departments of Otolaryngology–Head and Neck Surgery (Drs Calhoun and Driscoll), Clinical Affairs (Ms Stonestreet), and Healthcare Financial Management (Ms Averyt), University of Texas Medical Branch, Galveston; and the Department of Otolaryngology–Head and Neck Surgery, University of West Virginia, Morgantown (Dr Rassekh).


RELATED ARTICLE

Archives of Otolaryngology–Head & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2001;127(9):1146-1148.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effective health care: management of head and neck cancers
Collins et al.
Qual Saf Health Care 2005;14:144-148.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.